Literature DB >> 14556433

Pharmacologic features of proton pump inhibitors and their potential relevance to clinical practice.

Lynda S Welage1.   

Abstract

In conclusion, PPIs differ slightly in their PK and PD properties and in their propensity to interact with other medications. Inhibition of acid secretion is a function of proton pump inhibition, and PPIs work in a similar fashion to achieve this goal. PK/PD principles can be used to optimize PPI therapy when considering issues related to administration, such as timing of drug delivery relative to the number of active pumps and the drug's AUC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556433     DOI: 10.1016/s0889-8553(03)00056-6

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  6 in total

1.  Efficacy of S-pantoprazole 20 mg compared with pantoprazole 40 mg in the treatment of reflux esophagitis: a randomized, double-blind comparative trial.

Authors:  Yu Kyung Cho; Myung-Gyu Choi; Young-Tae Bak; Poong-Lyul Rhee; Sang Gyun Kim; Hoon-Yong Jung; Sang Young Seol
Journal:  Dig Dis Sci       Date:  2012-07-08       Impact factor: 3.199

2.  A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers.

Authors:  Sandy H Pang; David Y Graham
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

3.  Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.

Authors:  Hui-Wen Jiao; Lu-Ning Sun; Yue-Qi Li; Lei Yu; Hong-Wen Zhang; Mei-Feng Wang; Li-Yuan Yu; Zi-Qing-Yun Yuan; Li-Jun Xie; Juan Chen; Ling Meng; Xue-Hui Zhang; Yong-Qing Wang
Journal:  Eur J Clin Pharmacol       Date:  2017-11-22       Impact factor: 2.953

4.  Comparative clinical trial of S-pantoprazole versus racemic pantoprazole in the treatment of gastro-esophageal reflux disease.

Authors:  Vikas G Pai; Nitin V Pai; Hemant P Thacker; Jaisingh K Shinde; Vijay P Mandora; Subhash S Erram
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

5.  A cooperation project between hospital pharmacists and general practitioners about drug interactions in clinical practice.

Authors:  Valeria Vinciguerra; Roberto Fantozzi; Clara Cena; Roberta Fruttero; Carla Rolle
Journal:  Eur J Hosp Pharm       Date:  2017-08-01

6.  Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled Trial.

Authors:  Yu Kyung Cho; Myung-Gyu Choi; Hyojin Park; Ji Won Kim; Dong Ho Lee; Kwang Hyun Ko; Sang Gyun Kim; Hwoon-Yong Jung; Su Jin Hong; Yong Chan Lee; Si Hyung Lee
Journal:  J Neurogastroenterol Motil       Date:  2021-04-30       Impact factor: 4.924

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.